Skip to main content
. Author manuscript; available in PMC: 2014 May 2.
Published in final edited form as: Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007482. doi: 10.1002/14651858.CD007482.pub2
Methods RCT; 2 parallel groups.
Unit of randomization: individual.
Participants Dates of data collection; not reported.
Setting: University of Michigan Medical Center, Ann Arbour, Michigan, US
Inclusion criteria: women in labor.
Exclusion criteria: acute bleeding due to abruptio placentae, infection on treatment; abnormal renal function, penicillin allergy
Interventions Cephalothin 2 g IV within 1 hour of operation and at 4 and 8 hours after (N = 40) vs comparable appearing placebo (N = 40)
Outcomes Febrile morbidity (oral temperature > 100.3°F twice 6 hours apart); infection of endometrium, urinary tract and wound (definitions not provided); fever index (40 degree hours for treatment group vs 83 for placebo group)
Notes Class of antibiotic: first generation cephalosporin.
Subgroups:
  • non-elective CS;

  • before cord clamping.

Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Selected in random …manner”. No further information provided.
Allocation concealment? Unclear No information provided.
Blinding? Yes Double blind, placebo controlled.
All outcomes “The placebo was comparable to the cephalothin in both appearance and viscosity of solution.”
Incomplete outcome data addressed? Unclear No loss to follow up or exclusion of participants after randomization described, but results of only 80/85 participants reported Insufficient detail to know if the analysis was ITT.
All outcomes
Free of selective reporting? Unclear Insufficient information to judge.
Free of other bias? Unclear The 2 groups were comparable, but insufficient information overall
Overall low risk of bias? Unclear Mostly unclear.
HHS Vulnerability Disclosure